By Denny Jacob
Metagenomi Technologies filed for an initial public offering.
The precision genetics medicines company didn’t provide details on how many shares it was planning to offer or where it expects to price those shares.
Metagenomi applied to list its common stock on the Nasdaq Global Select Market under the ticker MGX.
Write to Denny Jacob at [email protected]
Read the full article here
